FDA Grants Modified Risk Authorization to 22nd Century Group’s VLN
22nd Century Group, Inc., a leading agricultural biotechnology company that is focused on tobacco harm reduction and reduced nicotine tobacco products, has announced that...
FDA Authorizes Philip Morris USA to Sell IQOS in U.S.
Altria Group, Inc. has revealed that it has received authorization from the U.S. Food and Drug Administration (FDA) to sell its heat-not-burn device, IQOS,...
Philip Morris International’s Revenue and Stock Jumps Due to IQOS
Philip Morris International (PMI) can thank the emerging market of heat-not-burn for not only meeting but beating recent revenue estimates.
Earlier this year, the U.S....
Altria Invests More in Reduced Harm Tobacco Product Category
Altria has long been known for its traditional cigarette products but the company's new focus could make it a leader in the reduced harm...
Philip Morris International to Regain Full U.S. Commercial Rights to IQOS
Altria has reached an agreement with Philip Morris International (PMI) relating to the IQOS Tobacco Heating System. Altria has revealed that it will receive...
Foundation For a Smoke-Free World’s Ties to Philip Morris International Questioned
The Foundation For a Smoke-Free World has sent a letter to 344 public health researchers and groups, offering $1 billion in grants. While this...
